4
Changes in Ownership
PTC THERAPEUTICS, INC. Filed Acc 0001415889-25-021130
CHIEF EXECUTIVE OFFICER sold 10,739 shares at $51.74 ($555,636)
- CHIEF EXECUTIVE OFFICER acquired 75,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Klein Matthew B. · CHIEF EXECUTIVE OFFICER
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-01 | Grant or award : show line 1 in the form 10b5-1 | +75,000 | 348,506 | D | ||
| 2025-08-05 | Sale : show line 2 in the form 10b5-1 | −10,739 | $51.74 | $555,636 | 337,767 | D |
| Open-market sales · 10,739 sh · avg $51.74 · $555,636 | ||||||
Loading xslF345X05/form4-08052025_080801.xml…